Drug Can Keep Leukemia in Remission for Years in Younger Patients

By Robert PreidtHealthDay Reporter TUESDAY, Dec. 14, 2021 (HealthDay News) — For certain leukemia patients, some welcome findings: New research confirms long remissions after treatment with the drug ibrutinib and chemotherapy. The study involved 85 patients with chronic lymphocytic leukemia (CLL). All were 65 or younger, and 46 had more aggressive, unmutated IGHV subtype of … Read more